Trade Summary

6 days ago, Camblong Jurgi, serving as Chief Executive Officer at SOPHiA GENETICS SA (SOPH), sold 8,500 shares at $5.24 per share, for a total transaction value of $44,500.90. Following this transaction, Camblong Jurgi now holds 3,620,995 shares of SOPH.

This sale represents a 0.23% decrease in Camblong Jurgi's stake in the company.

The trade was executed on Wednesday, June 10, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, June 11, 2026 at 4:05 PM ET, 1 day after the trade was made.

SOPHiA GENETICS SA operates in the HEALTHCARE sector, specifically within the HEALTH INFORMATION SERVICES industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.